First Manhattan CO Tandem Diabetes Care Inc Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$60.05 - $98.92 $240,200 - $395,680	-4,000 Reduced 50.0%	4,000 $395,000
Q4 2019 Feb 13, 2020	SELL	$53.13 - $71.19 $44,629 - $59,799	-840 Reduced 9.5%	8,000 $476,000
Q2 2019 Aug 16, 2019	SELL	$54.41 - $71.7 $63,115 - $83,172	-1,160 Reduced 11.6%	8,840 $570,000
Q3 2018 Oct 15, 2018	SELL	$21.39 - $51.17 $113,367 - $271,201	-5,300 Reduced 34.64%	10,000 $428,000
Q2 2018 Aug 01, 2018	BUY	$4.9 - $23.64 $74,970 - $361,692	15,300 New	15,300 $336,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.